A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2011
11/17/2011	WO2011141713A1 New bicyclic compounds as pi3-k and mtor inhibitors
11/17/2011	WO2011141004A1 Cefodizime sodium hydrate, preparation method and uses thereof
11/17/2011	WO2011140984A1 Anti-hbv polypeptide, pharmaceutical composition and use thereof
11/17/2011	WO2011140832A1 Hexaketide compound and medicinal use thereof
11/17/2011	WO2011091319A3 Dendritic cell vaccines
11/17/2011	WO2011090885A3 Enhanced anti-microbial pdt
11/17/2011	WO2011082331A3 Compositions and methods for treating hepatitis b virus infection
11/17/2011	WO2011079260A3 Stabilized virus like particles having enhanced mucosal immunogenicity
11/17/2011	WO2011071904A3 Inhibiting bacterial infection and biofilm formation
11/17/2011	WO2011068941A3 Proline derivatives
11/17/2011	WO2011062955A3 Compounds for modulating tlr2
11/17/2011	US20110282464 Reactive Surgical Implants
11/17/2011	US20110281946 Polymeric -based composition
11/17/2011	US20110281927 Deuterium-enriched doripenem
11/17/2011	US20110281921 Novel anti-biofilm agents
11/17/2011	US20110281918 Antifungal Composition
11/17/2011	US20110281913 Melanocortin receptor antagonist compounds, process for preparing them and use thereof in human medicine and cosmetics
11/17/2011	US20110281910 Hepatitis C Virus Inhibitors
11/17/2011	US20110281900 Crystalline Pharmaceutical
11/17/2011	US20110281878 INHIBITORS OF p38
11/17/2011	US20110281867 Compositions and methods of use for tyrosine kinase inhibitors to treat pathogenic infection
11/17/2011	US20110281864 Pyrido[3,2-d]Pyridazine-2(1H)-One Compounds as p38 Modulators and Methods of Use Thereof
11/17/2011	US20110281861 Thiazopyrimidinones and uses thereof
11/17/2011	US20110281860 Use of quinazoline derivatives for the treatment of viral diseases
11/17/2011	US20110281857 Pi3k/mtor kinase inhibitors
11/17/2011	US20110281841 Kinase Inhibitors
11/17/2011	US20110281840 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
11/17/2011	US20110281839 Combination therapy for the treatment of bacterial infections
11/17/2011	US20110281838 5-alkynyl-pyrimidines
11/17/2011	US20110281833 Composition for the Treatment of Ear Infections and Method
11/17/2011	US20110281831 Novel dermaceutical cream made using sodium fusidate, antifungals and steroids
11/17/2011	US20110281830 Novel dermaceutical cream made using sodium fusidate and steroids
11/17/2011	US20110281827 Compositions, gels and foams with rheology modulators and uses thereof
11/17/2011	US20110281824 Benzofuran derived hiv protease inhibitors
11/17/2011	US20110281822 Aromatic compounds having sphingosine-1-phosphonate (s1p) receptor activity
11/17/2011	US20110281811 Use Of Leukotriene Inhibitors For Treating Lung Diseases In Prematurely Born Infants
11/17/2011	US20110281810 Composition
11/17/2011	US20110281809 Methods and compositions for rapid treatment of otitis externa
11/17/2011	US20110281789 Ulbp antibodies
11/17/2011	US20110281788 Anti fungal therapy
11/17/2011	US20110281787 Pharmaceutical compositions comprising antisense oligonucleotides and methods of using same
11/17/2011	US20110281292 Compositions and methods for identifying antigens which elicit an immune response
11/17/2011	US20110280975 Composition comprising bamboo extract and the compounds isolated therefrom showing activity for the treatment and prevention of inflammatory and blood circulation disease
11/17/2011	US20110280957 Use of Finely Dispersed Metal Particles in a Material, a Skin Patch and an Orthopedic Article
11/17/2011	US20110280930 Products and methods for stimulating an immune response
11/17/2011	US20110280928 Wound Care Device Having Fluid Transfer Properties
11/17/2011	US20110280922 Devices and methods for treating and/or preventing diseases
11/17/2011	US20110280921 Antibacterial hydrogel and use thereof in orthopedics
11/17/2011	US20110280908 Multimeric protein toxins to target cells having multiple identifying characteristics
11/17/2011	US20110280907 Method and system for building a phylogeny from genetic sequences and using the same for recommendation of vaccine strain candidates for the influenza virus
11/17/2011	US20110280906 Method for augmenting the immunogenicity of an antigen
11/17/2011	US20110280905 Live attenuated chimeric porcine circovirus vaccine
11/17/2011	US20110280904 Generation of virus-like particles and use as panfilovirus vaccine
11/17/2011	US20110280903 Immunostimulatory combinations
11/17/2011	US20110280900 Clostridium chauvoei polypeptide, dna encoding the polypeptide and a vaccine comprising the polypeptide
11/17/2011	US20110280899 Novel Immunogenic Lipopeptides Comprising T-Helper And Cytotoxic T-Lymphocyte (CTL) Epitopes
11/17/2011	US20110280877 Inhibition of B7-H1/CD80 interaction and uses thereof
11/17/2011	US20110280873 MCP1-Ig FUSION VARIANTS
11/17/2011	US20110280859 Preventing and treating sepsis
11/17/2011	US20110280854 Compositions and methods for the treatment or the prevention of e. coli infections and for the eradication or reduction of e. coli surfaces
11/17/2011	US20110280853 Compositions and methods for treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces
11/17/2011	US20110280851 Compositions Comprising Cranberry Extract and Methods of Use Thereof
11/17/2011	US20110280847 Methods and compositions for inhibiting clostridium difficile spore germination and outgrowth
11/17/2011	US20110280845 Treatment of rheumatoid arthritis using placental stem cells
11/17/2011	US20110280841 Electroprocessing in Drug Delivery and Cell Encapsulation
11/17/2011	US20110280836 Compositions for bacterial mediated gene silencing and methods of using the same
11/17/2011	US20110280835 Commensal bacteria as signal mediators within a mammalian host
11/17/2011	US20110280832 Eotaxin-2 (ccl24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders
11/17/2011	US20110280831 Combinations comprising methotrexate and dhodh inhibitors
11/17/2011	US20110280830 Albumin Fusion Proteins
11/17/2011	US20110280828 Methods for treatment of microbial disorders
11/17/2011	US20110280824 Furanone Copolymers
11/17/2011	US20110280813 Neuraminidase inhibitors and uses thereof
11/17/2011	US20110280800 Il-1 binding proteins
11/17/2011	DE102010022174A1 Neue Darreichungsformen für Cineol New forms of cineole
11/17/2011	DE102010020567A1 Metallkomplexe Metal complexes
11/17/2011	CA2835489A1 Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses
11/17/2011	CA2799416A1 Compositions and methods for targeting a3g:rna complexes
11/17/2011	CA2799146A1 Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine
11/17/2011	CA2798946A1 Darunavir compositions
11/17/2011	CA2798924A1 Improved methods for preparing squalene
11/17/2011	CA2798856A1 Immunostimulatory and vaccine compositions
11/17/2011	CA2798328A1 Yeast cell wall components and detection thereof
11/16/2011	EP2386630A1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
11/16/2011	EP2386629A1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
11/16/2011	EP2386565A2 Compounds and methods to inhibit or augment an inflammatory response
11/16/2011	EP2386557A1 Novel substituted imidazoquinolines
11/16/2011	EP2386553A1 Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
11/16/2011	EP2386551A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
11/16/2011	EP2386550A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
11/16/2011	EP2386545A1 Heteroaryl ureas containing nitrogen hetero-atoms as P38 kinase inhibitors
11/16/2011	EP2386294A2 Unitary pharmaceutical dosage form comprising Tenofovir DF
11/16/2011	EP2385951A2 Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections
11/16/2011	EP2385838A1 Cyclosporine derivative for use in the treatment of hcv and hiv infection
11/16/2011	EP2385836A1 Pharmaceutical composition to protect an animal against a disorder arising from an infection with a bacterium that belongs to the group of nocardioform actinomycetes
11/16/2011	EP2385835A1 Use of deuterium oxide for treating viral diseases of the eye
11/16/2011	EP2385834A1 Use of deuterium oxide for treating viral diseases of the respiratory tract
11/16/2011	EP2385833A1 Combination of a cyclosporine derivative and nucleosides for treating hcv
11/16/2011	EP2209789B1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
11/16/2011	EP2132216B1 Novel nucleoside analogs for treatment of viral infections

1 ... 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 ... 1798